CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases
Estimated time to complete activity: 1 hour 30 minutes
Compatible with all modern internet browsers and mobile devices
EDUCATIONAL OBJECTIVES
Review the development of CAR T-cells up to the present day
Understand the implementation of CAR T-cells in the treatment of autoimmune diseases
Assess the risks, reservations, opportunities, and future potential of CAR T in autoimmune diseases
TARGET AUDIENCE
This activity is designed for qualified rheumatologists of all levels of seniority, and other healthcare professionals involved or interested in CAR T-cell therapy for treating patients with inflammatory diseases.
PROGRAMME OVERVIEW
In this webinar, CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases, experts discuss the development of CAR T-cell therapy in oncology, including next-generation CARs. The application of CAR T to autoimmune diseases is then highlighted, alongside the potential risks and reservations associated with this therapeutic approach. This is followed by an interactive Q&A session between the audience and our panel of industry experts.
DISCLOSURE OF CONFLICTS OF INTEREST
CESAS Medical requires faculty, presenters, planners, managers, writers, and any other individuals who are in a position to influence the content of this activity to disclose any real and/or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly reviewed and resolved according to CESAS Medical policy.
Modules
| Title | Presenters | Video | Questions |
| CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases |
Professor Iain McInnes Professor Carl June Professor Georg Schett Professor Richard Furie |
1 hour 32 minutes |